Sunvepra (asunaprevir) / BMS  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sunvepra (asunaprevir) / BMS
SWITCH-1, NCT02583685: Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Recruiting
2
160
RoW
PR4 + LDV/SOF + ASV 4 wk, Pegasys®, Copegus®, Harvoni®, Sunvepra®, PR4 + LDV/SOF + SMV 4 wk, OLYSIO®, PR4 + LDV/SOF + ASV 6 wk, PR4 + LDV/SOF + SMV 6 wk, PR4 + LDV/SOF + ASV 8 wk, PR4 + LDV/SOF + SMV 8 wk, PR4 + LDV/SOF + ASV 12 wk, PR4 + LDV/SOF + SMV 12 wk
Humanity and Health Research Centre, Beijing 302 Hospital, Nanfang Hospital of Southern Medical University
Chronic Hepatitis C Infection
10/22
12/22

Download Options